These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 33764535

  • 1. Reply to the commentary by Ben-Ari and Delpire: Bumetanide and neonatal seizures: Fiction versus reality.
    Löscher W, Kaila K.
    Epilepsia; 2021 Apr; 62(4):941-946. PubMed ID: 33764535
    [Abstract] [Full Text] [Related]

  • 2. The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
    Welzel B, Schmidt R, Kirchhoff L, Gramer M, Löscher W.
    Epilepsy Behav; 2023 Feb; 139():109057. PubMed ID: 36586153
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel.
    Kaila K, Löscher W.
    Epilepsia; 2022 Jul; 63(7):1868-1873. PubMed ID: 35524446
    [Abstract] [Full Text] [Related]

  • 5. A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia.
    Johne M, Käufer C, Römermann K, Gailus B, Gericke B, Löscher W.
    Epilepsia; 2021 Jun; 62(6):1460-1471. PubMed ID: 33955541
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective.
    Johne M, Römermann K, Hampel P, Gailus B, Theilmann W, Ala-Kurikka T, Kaila K, Löscher W.
    Epilepsia; 2021 Apr; 62(4):920-934. PubMed ID: 33258158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clarifications regarding bumetanide for neonatal seizures.
    Staley KJ.
    Epilepsia; 2022 Jul; 63(7):1863-1867. PubMed ID: 35524444
    [Abstract] [Full Text] [Related]

  • 11. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
    Kahle KT, Staley KJ.
    Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
    [Abstract] [Full Text] [Related]

  • 12. Astrocytic NKCC1 inhibits seizures by buffering Cl- and antagonizing neuronal NKCC1 at GABAergic synapses.
    Nguyen TD, Ishibashi M, Sinha AS, Watanabe M, Kato D, Horiuchi H, Wake H, Fukuda A.
    Epilepsia; 2023 Dec; 64(12):3389-3403. PubMed ID: 37779224
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bumetanide potentiates the anti-seizure and disease-modifying effects of midazolam in a noninvasive rat model of term birth asphyxia.
    Welzel B, Johne M, Löscher W.
    Epilepsy Behav; 2023 May; 142():109189. PubMed ID: 37037061
    [Abstract] [Full Text] [Related]

  • 17. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy.
    Gharaylou Z, Tafakhori A, Agah E, Aghamollaii V, Kebriaeezadeh A, Hadjighassem M.
    CNS Drugs; 2019 Mar; 33(3):283-291. PubMed ID: 30784026
    [Abstract] [Full Text] [Related]

  • 18. CNS pharmacology of NKCC1 inhibitors.
    Löscher W, Kaila K.
    Neuropharmacology; 2022 Mar 01; 205():108910. PubMed ID: 34883135
    [Abstract] [Full Text] [Related]

  • 19. NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders.
    Ben-Ari Y.
    Trends Neurosci; 2017 Sep 01; 40(9):536-554. PubMed ID: 28818303
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.